Glucagon-like peptide-2 increases sucrase-isomaltase but not caudal-related homeobox protein-2 gene expression

被引:32
作者
Kitchen, PA
Fitzgerald, AJ
Goodlad, RA
Barley, NF
Ghatei, MA
Legon, S
Bloom, SR
Price, A
Walters, JRF
Forbes, A
机构
[1] St Marks Hosp, Harrow HA1 3UJ, Middx, England
[2] Imperial Canc Res Fund, London WC2A 3PX, England
[3] Univ London Imperial Coll Sci Technol & Med, Sch Med, London W12 0NN, England
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2000年 / 278卷 / 03期
关键词
total parenteral nutrition; cellular proliferation; jejunum; ileum;
D O I
10.1152/ajpgi.2000.278.3.G425
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
To determine the effect of glucagon-like peptide-2 (GLP-2) on sucrase-isomaltase and caudal-related homeobox protein-2 (Cdx-2) gene expression, male Wistar rats were divided into total parenteral nutrition (TPN)-fed and GLP-2-treated, TPN-fed groups. TPN was given via a jugular line, inserted under anesthesia, for 7 days. The treatment group received 40 mu g/day of GLP-2 intravenously with the TPN diet. The small intestine and colon were weighed and measured. Tissue was obtained from the jejunum, terminal ileum, and midcolon. RNA analysis, morphometry, and microdissection were performed. The weight of the small intestine of GLP-2-treated rats was greater than that of TPN-fed rats (P < 0.001). GLP-2 increased the mean metaphase arrests/crypt in both the jejunum and ileum (P < 0.001). Ileal expression of sucrase-isomaltase was increased by 1.6-fold (P < 0.05). Jejunal expression was increased by a similar amount, although not significantly (P = 0.08). There was no change in Cdx-2 gene expression. Thus GLP-2 can maintain small intestinal morphology and function, but effects on gene expression are not mediated by gross changes in the level of the mRNA for the homeobox protein Cdx-2.
引用
收藏
页码:G425 / G428
页数:4
相关论文
共 39 条
  • [1] Archer S B, 1996, Adv Surg, V29, P165
  • [2] Factors involved in the duodenal expression of the human calbindin-D9k gene
    Barley, NF
    Prathalingam, SR
    Zhi, P
    Legon, S
    Howard, A
    Walters, JRF
    [J]. BIOCHEMICAL JOURNAL, 1999, 341 : 491 - 500
  • [3] EXON DUPLICATION AND DIVERGENCE IN THE HUMAN PREPROGLUCAGON GENE
    BELL, GI
    SANCHEZPESCADOR, R
    LAYBOURN, PJ
    NAJARIAN, RC
    [J]. NATURE, 1983, 304 (5924) : 368 - 371
  • [4] GUT HORMONES IN ADAPTATION
    BLOOM, SR
    [J]. GUT, 1987, 28 : 31 - 35
  • [5] Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2
    Brubaker, PL
    Crivici, A
    Izzo, N
    Ehrlich, P
    Tsai, CH
    Drucker, DJ
    [J]. ENDOCRINOLOGY, 1997, 138 (11) : 4837 - 4843
  • [6] Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2
    Brubaker, PL
    Izzo, A
    Hill, M
    Drucker, DJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 272 (06): : E1050 - E1058
  • [7] Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2
    Chance, WT
    FoleyNelson, T
    Thomas, I
    Balasubramaniam, A
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1997, 273 (02): : G559 - G563
  • [8] CHEESEMAN CI, 1997, AM J PHYSIOL-REG I, V273, pR195
  • [9] CHRISTENSEN ML, 1993, CANCER-AM CANCER SOC, V72, P2732, DOI 10.1002/1097-0142(19931101)72:9<2732::AID-CNCR2820720934>3.0.CO
  • [10] 2-E